[1] | Phillips OP. Venous thromboembolism in the pregnant woman. J Reprod Med 2003; 48: 921-9. |
|
[2] | National Institutes of Health. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 1986; 256: 744-9. |
|
[3] | Hull RD, Raskob GE, Carter CJ. SeriallPG in pregnant patients with clinically suspected deep vein thrombosis: 1990; 112: 663-7. |
|
[4] | World Health Organization. Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. WHO; Geneva; 2004: 1-39. |
|
[5] | Bergqvist A, Bergqvist D, Lindhagen A, Matzsch T. Late symptoms after pregnancy-related deep vein thrombosis. Br J Obstet Gynaecol 1990; 97: 338-41. |
|
[6] | Pabinger I, Nemes L, Rintelen C, Koder S, Lechler E, Loreth RM et al. Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematol J 2000; 1: 37-41. |
|
[7] | Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3. |
|
[8] | Middeldorp S, Libourel EJ, Hamulyak K, van der Meer J, Bu¨ ller HR. The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 2001; 113: 553-5. |
|
[9] | Colman-Brochu S. Deep vein thrombosis in pregnancy. MCN Am J Matern Child Nurs. 2004; 29: 186-192. |
|
[10] | Hall JAG, Paut RM, Wilson KM. Maternal and fetal sequelaeb of anticoagulants during pregnancy. Am J Med 1980; 68: 122-40. |
|
[11] | Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335 (2): 108-14. |
|
[12] | Hall JAG, Paut RM, Wilson KM. Maternal and fetal sequelaeb of anticoagulants during pregnancy. Am J Med 1980; 68: 122-40. |
|
[13] | Wessler S. Medical management of venous thrombosis. Ann Rev Med 1976; 27: 313. |
|
[14] | Raes DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4. |
|
[15] | Ginsberg JS, Hirsh Rainbow AJ et al. Risks of the fetus radiological procedures used in the diagnosis maternal venous thromboembolic disease. Thromb Hemost 1989; 61: 189-96 |
|
[16] | World Medical Association Medical Ethics Committee, Updating the WMA Declaration of Helsinki. Wld Med J 1999, 45: 11-13. |
|
[17] | Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003 Apr; 29 (2); 125-30. |
|
[18] | Cerneca F, Ricci G, Simeone R, et al ‘Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis’ Eur J Obstet Gynecol Reprod Biol. 1997 May; 73 (1): 31-6. |
|
[19] | Lloyd R Whitfield, Amol S Lele, Gerhard Levy Amherst et al, Effect of Pregnancy on the relationship between concentration and anticoagulant action of heparin. Clinical Pharmacology and Therapeutics (1983) 34, 23-28; 1983. |
|
[20] | Hui C, Lili M, et al; Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases. Arch Gynecol Obstet. 2012 May; 285 (5): 1231-6. Epub 2011 Nov 15. PMID: 22083312 |
|
[21] | Szecsi PB, Jørgensen M, et al; Haemostatic reference intervals in pregnancy, Thromb Haemost. 2010 Apr; 103 (4): 718-27. Epub 2010 Feb 19. PMID: 2017476. |
|
[22] | Greer lA. Thrombosis in pregnancy: maternal and foetal issues. Lancet 1999; 353 (9160): 1258-65. |
|
[23] | Nihon Sanka Fujinka Gakkai Zasshi. A study of intrapartum and postpartum bleeding based on changes in blood coagulation and fibrinolysis during pregnancy. [Article in Japanese] 1987 Mar; 39 (3): 405-10. PMID: 3494090 |
|
[24] | BoehlenF, HohlfeldP, Extermann Petal. Plate let count atterm pregnancy: are appraisal of the threshold. Obstet Gynecol 2000; 95: 29-33. |
|